COCRYSTAL PHARMA, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
COCRYSTAL PHARMA, INC. (COCP) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of -$1.69 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-21.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2018-03-21
- COCRYSTAL PHARMA, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2013-12-31 was -$1.16M.
- COCRYSTAL PHARMA, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2013-09-30 was $685.65K.
- COCRYSTAL PHARMA, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was -$1.69M.
- COCRYSTAL PHARMA, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2014 was -$584.00K.
- COCRYSTAL PHARMA, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2013 was -$470.45K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$1.69M 10-K · filed 2018-03-21 | |||
| 2014-12-31 | -$584.00K 10-K · filed 2017-03-31 | |||
| 2013-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$470.45K derived: sum of 2 quarters · filed 2014-03-31 | -$470.45K 10-K · filed 2014-03-31 | |
| 2013-09-30 | $685.65K 10-Q · filed 2013-11-18 | $685.65K 10-Q · filed 2013-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |